XDx Registers for IPO

Brisbane, Calif.-based biotech firm XDx Inc. on Wednesday announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock.

XDx specializes in molecular diagnostics for the monitoring of transplant rejection and autoimmune diseases.

Just Posted

Sisters of Perpetual Indulgence may pull out of Folsom Street Fair

San Francisco’s iconic Folsom Street Fair could soon see a high-profile departure:… Continue reading

SF to form task force to address drug dealing in Tenderloin, SoMa

As the supervisor of the Tenderloin and SoMa neighborhood, Matt Haney said… Continue reading

Punch Line celebrates with ‘New Lease on Laughs’

Savvy Nato Green and friends save comedy club from eviction

SF’s newest subway may emerge on the West Side

San Francisco’s sleepy West Side — from the Richmond District to Parkmerced… Continue reading

Treasure Island residents could win new displacement protections

Supervisor working to give all current residents a chance to move into new development

Most Read